Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.92M P/E - EPS this Y 85.50% Ern Qtrly Grth -
Income -37.64M Forward P/E - EPS next Y -11.50% 50D Avg Chg -
Sales - PEG - EPS past 5Y - 200D Avg Chg -3.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -63.00%
Recommedations 1.50 Quick Ratio 0.14 Shares Outstanding 28.06M 52W Low Chg 86.00%
Insider Own 7.09% ROA -80.28% Shares Float 11.67M Beta 1.71
Inst Own 57.67% ROE - Shares Shorted/Prior -/- Price 0.02
Gross Margin - Profit Margin - Avg. Volume 1,098,677 Target Price 22.50
Oper. Margin - Earnings Date May 12 Volume 2,559,857 Change -4.21%
About SKYE BIOSCIENCE INC

Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

SKYE BIOSCIENCE INC News
04/10/24 Skye Bioscience Uplists to The Nasdaq Global Market
03/11/24 Skye Bioscience Announces $40 Million Private Placement Equity Financing
03/04/24 Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
02/26/24 Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
02/07/24 Skye Bioscience to Present at Oppenheimer Investor Conference
01/29/24 Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
01/09/24 Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
12/11/23 Skye Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab
12/08/23 Skye Bioscience Responds to OTC Markets Promotional Policy
12/05/23 Skye Bioscience and Tautomer Bioscience Enter Exclusive License for SBI-100 for Development and Sale of Products for Chronic Pain and Other Indications in South Africa and Rest of Africa
11/28/23 Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
11/21/23 Skye Bioscience to Present at BTIG Ophthalmology Day and OIS XIII Ophthalmology Innovation Summit
10/25/23 Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
11:59 PM CORRECTION: Skye Bioscience to Host Virtual Investor Day on October 25, 2023: "CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System"
06:00 AM Skye Bioscience to Host Virtual Investor Day on October 25, 2023: "CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System"
09/27/23 Skye Bioscience Receives Clinical Site Approvals for Glaucoma Phase 2a Trial
09/22/23 Skye Bioscience Announces Participation at Upcoming Investor Conferences
09/07/23 Skye Bioscience Reverse Stock Split to Be Effective on September 8th
09/05/23 Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference
08/21/23 Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
SKYE Chatroom

User Image aricray Posted - 1 hour ago

$SKYE It doesn't get any more real than this and get ready, because the game plan for growth coupled with this level of leadership and incomparable tech is going to blow some minds and make us all a lot of money.

User Image MissionaryTrader Posted - 2 hours ago

$SKYE if this volume trend continues, the SP will go higher!

User Image budfox09 Posted - 7 hours ago

$SKYE

User Image Multipliers Posted - 8 hours ago

$SKYE Here's the buy the dip opportunity you've been waiting for!

User Image WillS54 Posted - 19 hours ago

$SKYE Incredible. I bought this stock so long ago that it was called Emerald. Never threw it away because the vision was great. Absolutely incredible to see it ringing the opening bell on the Nasdaq today. Punit has delivered.

User Image Goatrs Posted - 1 day ago

$SKYE would have been nice for the Skye bell ringing group to celebrate the special day in the green...

User Image 916Investments Posted - 1 day ago

$SKYE Punit really did that

User Image budfox09 Posted - 1 day ago

$SKYE The reality of what you, @Multipliers, say below really does make me laugh as we watch the activity. How long do you think it will take them, the advisors/Investment firms, to figure out they are dealing with A LOT of Strong DIAMOND encrusted Hands, and that price will need to be bid up considerably before we are willing to release any of our shares? 🤔😁🙃

User Image RM_111 Posted - 1 day ago

$SKYE Beautiful !

User Image 4kjson Posted - 1 day ago

$SKYE Fantastic and historical moment for SKYE! https://x.com/NasdaqExchange/status/1780949562858864685

User Image budfox09 Posted - 1 day ago

$SKYE I'll be honest... Kind of Exciting !

User Image TJAY914 Posted - 1 day ago

$SKYE

User Image tml786 Posted - 1 day ago

$SKYE let’s go!!!

User Image Jangalang Posted - 1 day ago

$SKYE … did everyone see the post on X. SKYE is at NASDAQ today for the opening bill. That is crazy. Bullish AF

User Image MissionaryTrader Posted - 1 day ago

$SKYE

User Image Jangalang Posted - 1 day ago

$SKYE … Break $19 today?

User Image Min_1111 Posted - 1 day ago

$SKYE it's happening people. Can you feel it? And soon, I hope... news, to support continued incline. It'll be a good time after the bell rings to drop some news. 😄 I still haven't made my average yet on Schwab, but was able to buy last week on RH after uplisting, which is in a nice 50% profit.

User Image aricray Posted - 1 day ago

$SKYE Absolutely

User Image jackedmund99 Posted - 1 day ago

$SKYE the multi billion dollar dollar weight loss market looks for alternative Skye may be one solution as this revelation helps further skye’s appeal - read on https://nypost.com/2024/04/17/lifestyle/experts-reveal-why-ozempic-appears-to-change-peoples-personalities/?utm_campaign=iphone_nyp&utm_source=pasteboard_app

User Image slayer70 Posted - 1 day ago

$SKYE I wouldn't be surprised if this breaks the 52 wk- high.

User Image Jangalang Posted - 1 day ago

$SKYE … Wish I had some powder… Wouldnhave loaded up below $10

User Image Jangalang Posted - 1 day ago

$SKYE … SKYE’s the Limit…

User Image PONTOS Posted - 2 days ago

$SKYE

User Image Min_1111 Posted - 2 days ago

$SKYE

User Image 916Investments Posted - 2 days ago

$SKYE .

User Image Multipliers Posted - 2 days ago

$SKYE What do you make of today's crazy finish? I think people want in but are waiting for a dip that's probably never coming in any big way and at the of the day a few come to that realization and decide to slap that ask instead of letting it creep up day after day.

User Image MissionaryTrader Posted - 2 days ago

$SKYE

User Image Multipliers Posted - 2 days ago

@InvestInWhatYouKnow several new animal test, Carol Baskins endorsement, new CEO. It was a wild ride. I got in I recall at just under .2 and out at over $2. It was one of two stocks that I had the stomach to hold through the volatility to achieve a 10X+ return. The other was $sol. It went from about .8 to $33 in 2021. The 3rd will be $SKYE ! Not sure why Zom retraced. There are others on this board that were in Zom as well.

User Image jackedmund99 Posted - 2 days ago

$SKYE ya gotta like the way the chart is firming up

User Image RM_111 Posted - 2 days ago

$SKYE

Analyst Ratings
Oppenheimer Outperform Apr 12, 24
Piper Sandler Overweight Mar 14, 24
Piper Sandler Overweight Feb 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DHILLON PUNIT Chief Executive Offi.. Chief Executive Officer Aug 25 Buy 0.02 881,000 17,620 25,683,957 08/31/23